Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Preferred Shares Issued (2017)

Historic Preferred Shares Issued for Dianthus Therapeutics (DNTH) over the last 1 years, with Q3 2017 value amounting to $2.0 million.

  • Dianthus Therapeutics' Preferred Shares Issued changed N/A to $2.0 million in Q3 2017 from the same period last year, while for Dec 2018 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $100.0 million for FY2022, which is N/A changed from last year.
  • As of Q3 2017, Dianthus Therapeutics' Preferred Shares Issued stood at $2.0 million.
  • In the past 5 years, Dianthus Therapeutics' Preferred Shares Issued ranged from a high of $2.0 million in Q3 2017 and a low of $2.0 million during Q3 2017